Belvedere Trading LLC Atossa Therapeutics, Inc. Call Options Transaction History

Belvedere Trading LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$0.5 - $1.01 $25,750 - $52,015	51,500 New	51,500 $27,000
Q1 2022 Apr 20, 2022	SELL	$1.11 - $1.74 $64,158 - $100,572	-57,800 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$1.6 - $3.27 $19,520 - $39,894	-12,200 Reduced 17.43%	57,800 $73,000
Q3 2021 Oct 19, 2021	SELL	$2.89 - $6.4 $957,746 - $2.12 Million	-331,400 Reduced 82.56%	70,000 $195,000
Q2 2021 Jul 23, 2021	BUY	$1.52 - $8.62 $610,128 - $3.46 Million	401,400 New	401,400 $1.58 Million

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.